150 related articles for article (PubMed ID: 11527648)
1. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.
Rapacciuolo A; Esposito G; Caron K; Mao L; Thomas SA; Rockman HA
J Am Coll Cardiol; 2001 Sep; 38(3):876-82. PubMed ID: 11527648
[TBL] [Abstract][Full Text] [Related]
2. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.
Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA
Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
[TBL] [Abstract][Full Text] [Related]
5. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.
van Eickels M; Grohé C; Cleutjens JP; Janssen BJ; Wellens HJ; Doevendans PA
Circulation; 2001 Sep; 104(12):1419-23. PubMed ID: 11560859
[TBL] [Abstract][Full Text] [Related]
6. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.
Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA
Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881
[TBL] [Abstract][Full Text] [Related]
8. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
[TBL] [Abstract][Full Text] [Related]
9. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
11. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
12. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
13. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
14. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
Sadoshima J; Montagne O; Wang Q; Yang G; Warden J; Liu J; Takagi G; Karoor V; Hong C; Johnson GL; Vatner DE; Vatner SF
J Clin Invest; 2002 Jul; 110(2):271-9. PubMed ID: 12122119
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.
Yano M; Kim S; Izumi Y; Yamanaka S; Iwao H
Circ Res; 1998 Oct; 83(7):752-60. PubMed ID: 9758646
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of cardiac hypertrophy.
Yamazaki T; Yazaki Y
Z Kardiol; 2000 Jan; 89(1):1-6. PubMed ID: 10663910
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
Ogita H; Node K; Liao Y; Ishikura F; Beppu S; Asanuma H; Sanada S; Takashima S; Minamino T; Hori M; Kitakaze M
Hypertension; 2004 Feb; 43(2):237-42. PubMed ID: 14676219
[TBL] [Abstract][Full Text] [Related]
18. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
